Woman Man | 18 years and more
- | Country :
- France
- | organs :
- Utérus
- | Specialty :
- Thérapies Ciblées
Extract
A randomized, double blind, placebo controlled, parallel group study of the safety and the response rate as to histologic resolution of 3 sc administered doses of RO5217790 in patients with high grade cervical intraepithelial neoplasia associated with high risk HPV infection.
Scientific Abstract
en cours d'intégration;